DNDN’s prostate trial is one of the very few follow-on trials in a subset where I consider the underlying medical hypothesis strong enough to expect a reasonable chance of success.
Most subset trials are really just fishing expeditions.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”